Related Experiment Video
Updated: Mar 10, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Developmental Outcomes of Preterm Infants With Neonatal Hypoglycemia
Rachel H Goode1, Mallikarjuna Rettiganti2, Jingyun Li2
1Department of Pediatrics, Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee; rachel.goode@vanderbilt.edu.
Insights
Neonatal hypoglycemia in preterm infants did not significantly impact cognitive or academic skills. While behavioral differences were noted at age 18, they were not clinically meaningful, suggesting no long-term neurodevelopmental issues.
Area of Science:
- Neonatal care
- Developmental pediatrics
- Neuroscience
Background:
- Neonatal hypoglycemia is linked to potential neurodevelopmental issues, but studies present conflicting evidence.
- Previous research on the long-term effects of neonatal hypoglycemia on preterm infants remains inconclusive.
- Understanding the neurodevelopmental outcomes is crucial for effective neonatal care strategies.
Purpose of the Study:
- To compare cognitive, academic, and behavioral outcomes in preterm infants with and without neonatal hypoglycemia.
- To investigate long-term effects up to 18 years of age.
- To clarify the association between neonatal hypoglycemia and neurodevelopmental trajectories in preterm infants.
Main Methods:
- Secondary analysis of the Infant Health and Development Program cohort.
- Stratification of 745 preterm infants into four glucose level groups.
- Standardized cognitive, academic, and behavioral assessments at 3, 8, and 18 years, adjusting for multiple covariates.
Main Results:
- No significant differences in cognitive or academic skills were found between hypoglycemic and normoglycemic preterm infants.
- Infants with more severe neonatal hypoglycemia reported fewer problem behaviors at age 18.
- The observed behavioral difference at age 18 was statistically significant but not clinically meaningful.
Conclusions:
- Neonatal hypoglycemia in preterm infants is not associated with significant long-term intellectual or academic deficits.
- While a statistical behavioral difference was observed at age 18, it lacks clinical significance.
- Findings align with previous studies indicating no major neurodevelopmental impairment from neonatal hypoglycemia in this population.
Background And Objectives:
Neonatal hypoglycemia has been associated with abnormalities on brain imaging and a spectrum of developmental delays, although historical and recent studies show conflicting results. We compared the cognitive, academic, and behavioral outcomes of preterm infants with neonatal hypoglycemia with those of normoglycemic controls at 3 to 18 years of age.
Methods:
A secondary analysis of data from the Infant Health and Development Program, a national, multisite, randomized controlled longitudinal intervention study of long-term health and developmental outcomes in preterm infants. Of the 985 infants enrolled in the Infant Health and Development Program, 745 infants had glucose levels recorded. Infants were stratified into 4 groups by glucose level. By using standardized cognitive, academic, and behavioral assessments performed at 3, 8, and 18 years of age, we compared groups after adjusting for intervention status, birth weight, gestational age, sex, severity of neonatal course, race, maternal education, and maternal preconception weight.
Results:
No significant differences were observed in cognitive or academic skills between the control and effected groups at any age. Participants with more severe neonatal hypoglycemia reported fewer problem behaviors at age 18 than those without hypoglycemia.
Conclusions:
No significant differences in intellectual or academic achievement were found between preterm infants with and without hypoglycemia. A statistical difference was found in behavior at age 18, with hypoglycemic children showing fewer problematic behaviors than normoglycemic children. This difference was not clinically meaningful. Using extended outcomes, our results are consistent with previous studies that found no significant neurodevelopmental outcomes associated with neonatal hypoglycemia in preterm-born children.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Inborn Errors of Metabolism
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Teratogenicity

